Aktywny
BioNTech
Pioneer of mRNA-based immunotherapies
Producenci
- Kraj
- Germany
- Rok założenia
- 2008
- Miasto siedziby
- —
- Adres siedziby
- An der Goldgrube 12, 55131 Mainz, Germany
- info@biontech.de
- Telefon
- +49 6131 90840
- Strona WWW
- https://www.biontech.com/
O firmie
Founded in 2008 by Uğur Şahin and Özlem Türeci, BioNTech specializes in mRNA-based vaccines and cancer immunotherapies. Co-developed the first approved mRNA COVID-19 vaccine with Pfizer.
Szczepionki
Brak danych
FAQ
Brak elementów FAQ.